Prevalence and clinical significance of antinuclear antibodies in Iranian women with unexplained recurrent miscarriage

Antinuclear antibodies [ANAs] in women with recurrent miscarriage have been reported. The presence of moderate to high titers of these antibodies represents an autoimmune condition that can endanger the health of the fetus in pregnant women. In this study, we evaluated the prevalence of ANAs in Iranian women with a history of two or more unexplained abortion. 560 women with unexplained recurrent miscarriage and 560 healthy controls accounted for this study over a period of 13 months. ANAs were detected by indirect immunofluorescence technique. ANAs were detected in 74 of 560 [13.21%] patient with recurrent miscarriage, and in only 5 of 560 [0.9%] controls [p<0.001]. ANA positivity was generally found with low-positive results [1.40-1.80] in about 38% of positive cases, whereas moderate titres [1.160-1.320] and high titres [>1.640] were seen in about 46% and 16% of cases respectively. Finally evaluating of microscopic ANA patterns revealed that about half of positive cases had antibodies against DNA- histone complex, associated with systemic lupus erythematosus disease. Antinuclear antibodies are not uncommon in women with unexplained recurrent miscarriage, suggesting the possible role of an autoimmune disorder on abortion, at least in a subgroup of patients

Efficacy of a combined rosemary and lavender topical ointment in the treatment of patients with osteoarthritis of the knee

One of the preservative treatments of knee osteoarthritis is the use of topical medications. This study is aimed to clinically evaluate the effect of topical products containing essential oils of rosemary and lavender herbs on the treatment of patients with osteoarthritis of the knee. Rosemary and lavender essential oils were prepared by steam distillation method and inserted into the ointment with the hydrophilic base. In this study, 15 patients with knee osteoarthritis were treated with this ointment for three months. The results were assessed using WOMAC and Lequesne indices and were evaluated by the Wilcoxon statistical test. At the week of admission to the hospital, mean WOMAC index was equal to 71.4, mean Lequesne index was equal to 18 and the average time of passing through the distance of fifty feet by patients was equal to 19.4. After 4, 8 and 12 weeks, all these indices significantly decreased [p

Distribution of HLA-B*27 alleles in patients with ankylosing spondylitis in Iran

HLA-B*27 is strongly associated with ankylosing spondylitis [AS]. It represents a family of alleles that differ among ethnic groups. The aim of this study was to determine the distribution of HLA-B*27 alleles in AS patients and healthy controls in Isfahan [Iran]. Sixty AS patients and 430 healthy blood donors were selected. All subjects were HLA-B*27 positive by flow cytometry. HLA-B*27 subtypes were determined by PCR-SSP. Forty patients [66.7%] and 17 controls [3.95%] were HLA-B*27 positive. Subtypes detected by PCR-SSP were B*2705, B*2702, B*2704 and B*2707. One patient was B*2702/B*2710. No significant difference was found in the distribution of these alleles between AS patients and controls. Although Caucasian subtypes are predominant among Iranians, this population is characterized by a combination of both specific Caucasian and Oriental subtypes. However such results should be interpreted carefully because of the small sample size in our investigation and definitive conclusion awaits more ethnic-group studies

flowcytometry study of cd55 and cd59 expression on erythrocytes in rheumatoid arthritis patients

Inappropriate activation or blockage of the inhibition of complement system could cause tissue damages in autoimmune diseases particularly rheumatoid arthritis [RA]. Defect in complement component regulation may cause damages to tissues, on the other hand, or the damaged tissue might affect the unnecessary activation of complement components. To investigate the expression of CD55 and CD 59 complement regulatory proteins in RA patients. Fifty proved rheumatoid arthritis patients participated in this study and their blood were collected for investigations. CD55 and CD59 molecules expression on the erythrocytes was assayed using primary monoclonal antibody and secondary FITC conjugated Ab, then the prepared samples were run with a FACSCalibur flowcytometer [Becton-Dickinson] and the obtained data was analyzed using a Cell Quest software package. To evaluate the complement function, CH50 was performed using patient sera. All experiments were done with a matched healthy volunteer group. The mean fluorescence intensity for CD55 was 27.6 +/- 13.4 arbitrary unit for patients and 68.5 +/- 10.5 for healthy group. CD59 mean fluorescence intensity was 314 +/- 83 in patient group and 508 +/- 56 in healthy volunteers. In addition, there was a significant difference between CH50 in patients [54.5 +/- 15.5] and in healthy group [110 +/- 20]. A significant correlation between CD55 and CD59 expansion on the patient erythrocytes was found [P = 0.00, r = 0.576]. No association was found between CD59, or CD55 with CH50 [P > 0.05]. The expression of CD55 and CD59 is down-regulated on erythrocytes of patients with RA. Change in expression of regulatory complement components in RA may be a useful key for the assessment of disease progression or in patients' follow-up